Please login to the form below

Not currently logged in
Email:
Password:

Aptiv Solutions promotes Dr Phil Birch and Carolyn Belcher

The US contract research organisation said the appointments fill key strategic posts

US contract research organisation (CRO) Aptiv Solutions has made changes to its executive team, promoting Dr Phil Birch and Carolyn Belcher.

Dr Birch, previously senior vice president of global regulatory at the CRO, will step up to the newly-created position of senior vice president and corporate brand manager for adaptive clinical trials.

In his new role he will focus on brand development, market education and developing strategic partnerships across the business. Prior to joining the company he spent five years at Fulcrum Pharma as general manager, Europe.

Aptiv's other executive change sees former Novartis employee Carolyn Belcher replace Dr Birch as senior director and global head of the Aptiv Solutions Regulatory Business Unit.

Her other previous roles include a stint as a clincial research scientist in the UK's NHS as well as senior director and global head of regulatory affairs and strategic drug development services at SRA Global Clinical Development.

Pat Donnelly, Aptiv's chairman and CEO, said: “This past year, we have seen a dramatic increase in sponsor interest in pursuing adaptive design clinical trials and as an organisation we are aligning strong leadership and expertise to focus internal resources to help our clients develop, design and execute best-in-class adaptive clinical programmes.”

5th December 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics